CGAS and cancer: HER2 expression has recently been found to suppress antiviral defenses and antitumor immunity as a result of HER2 signaling through its intracellular domain, which interferes with cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway and prevents cancer cell death [45].